2027 Summer Intern – Translational Safety (Bioinformatics)
Genentech
Summary
We are now accepting applications for the Genentech 2027 Summer Internship Program in Development Sciences (DevSci); this post is for a computational biology role in Translational Safety (TS). Translational Safety is an integral part of DevSci. We contribute to the organization's success by providing scientific insights and ensuring the safety of molecules that advance through the pipeline to patients.
Job description
Department Summary
We are now accepting applications for the Genentech 2027 Summer Internship Program in Development Sciences (DevSci); this post is for a computational biology role in Translational Safety (TS). Translational Safety is an integral part of DevSci. We contribute to the organization's success by providing scientific insights and ensuring the safety of molecules that advance through the pipeline to patients.
The selected candidate will use dose-resolved single-cell RNA-seq data to model how cell populations respond to chemical perturbations. The intern will benchmark foundation models alongside other computational approaches for capturing dose-dependent responses and predicting the effects of previously unseen compounds. The project will also compare in vitro perturbation states with relevant in vivo cellular programs to identify response features that are most informative for human-relevant toxicology.
This internship position is located in South San Francisco, on-site.
The Opportunity
- Model perturbation responses: Develop and benchmark computational approaches to capture reproducible, dose-dependent cellular responses.
- Test generalization: Evaluate whether learned response patterns can predict the effects of compounds not used during model development.
- Interpret mechanisms of toxicity: Integrate transcriptomic responses with biological pathways, chemical properties, and toxicological information to understand cellular stress and injury.
- Assess translational relevance: Compare in vitro perturbation signatures with relevant in vivo cellular programs to evaluate their relevance for human safety.
Program Highlights
- Intensive 12-weeks, full-time (40 hours per week) paid internship.
- Program start dates are in May/June (Summer).
- A stipend, based on location, will be provided to help alleviate costs associated with the internship.
- Ownership of challenging and impactful business-critical projects.
- Work with some of the most talented people in the biotechnology industry.
Who You Are
Required Education
Must be pursuing a PhD (enrolled student).
Required Majors: STEM major (preferably in Toxicology or related) with coursework in Bioinformatics, Computational Biology, Data Science, Computer Science, Bioengineering or similar.
Required Skills
- Proficient in coding with R or Python.
- Experience working in an HPC/cloud environment to manage large biological datasets.
- Familiarity with machine learning frameworks or predictive modeling.
- Experience analyzing transcriptomic, proteomic, or other high-dimensional biological data.
Preferred Knowledge, Skills, And Qualifications
- Knowledge of liver biology and toxicology.
- Previous experience working with single-cell perturbation data is highly desirable.
- Excellent communication, collaboration, and interpersonal skills.
Requirements
- Must be pursuing a PhD (enrolled student)
- STEM major (preferably in Toxicology or related) with coursework in Bioinformatics, Computational Biology, Data Science, Computer Science, Bioengineering or similar
- Proficient in coding with R or Python
- Experience working in an HPC/cloud environment to manage large biological datasets
- Familiarity with machine learning frameworks or predictive modeling
- Experience analyzing transcriptomic, proteomic, or other high-dimensional biological data
- Knowledge of liver biology and toxicology (preferred)
- Previous experience working with single-cell perturbation data (preferred)
- Excellent communication, collaboration, and interpersonal skills
Benefits
- Paid Internship
- Stipend
- Paid Holiday Time Off
Company overview
Genentech, founded in 1976 and now a member of the Roche Group, is widely recognized as the pioneer of the biotechnology industry. The company has been at the forefront of scientific innovation for nearly 50 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. With over 10,000 employees, the company operates from its South San Francisco headquarters and maintains a strong focus on oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Genentech continues to pursue groundbreaking science while maintaining its startup spirit within the Roche organization, consistently delivering on its promise to improve patients' lives through innovative biopharmaceutical solutions.